No Data
RBC Capital has lowered the target price for CVS Health to $58.
RBC Capital: lowered the target price of CVS Health from $68 to $58, maintaining an "outperform large cap" rating. (Gelonghui)
CVS Health's 2025 'Less Certain' Following 2024 Guidance Withdrawal, Changes in Leadership, RBC Capital Says
Large Pension Doubled Palantir Stake, Bought Up Intel and CVS Stock
CVS Health (NYSE:CVS) Sheds US$3.0b, Company Earnings and Investor Returns Have Been Trending Downwards for Past Three Years
Weekly Buzz: Not All Parties Last Forever
Market Falls to End All-Time High Week | Wall Street Today